Ian Clark

Ian Clark

Net worth: 2 M $ as of 29/04/2026

65 year
Health Technology
Commercial Services
Consumer Non-Durables

Profile

Ian T.
Clark
is currently Chairman at X-Vax Technology, Inc., Olema Pharmaceuticals, Inc., and BioMarin Pharmaceutical, Inc. (starting 2025).
Holds the position of Lead Independent Director at Guardant Health, Inc. since 2016.
Serves as Independent Director at Corvus Pharmaceuticals, Inc. since 2017, Takeda Pharmaceutical Co., Ltd. since 2019, and Kyverna Therapeutics, Inc. starting 2026.
Director at Asher Biotherapeutics, Inc. since 2022.
Member of TechNet.
Formerly Chief Executive Officer & Director at Genentech, Inc. from 2010 to 2016.
Director at Ligand UK Ltd., Biotechnology Innovation Organization, The Bioindustry Association, Vernalis (R&D) Ltd., Gladstone Foundation (CA), Vernalis Therapeutics, Inc., Solazyme, Inc., and IVAX LLC.
Director at Dendreon Corp.
and Dendreon Pharmaceuticals LLC from 2009 to 2010.
Independent Director at TerraVia Holdings, Inc. from 2012 to 2017, Shire Plc from 2017 to 2019, Agios Pharmaceuticals, Inc. from 2016 to 2022, Forty Seven LLC from 2018 to 2020, Kite Pharma, Inc. in 2017, AVROBIO, Inc. from 2018 to 2024, and Gyroscope Therapeutics Holdings Plc from 2019 to 2022.
Director at Shire Pharmaceuticals, Inc. from 2017 to 2019.
Independent Non-Executive Director at Shire Plc from 2017 to 2019.
Chief Operating Officer at Novartis Pharmaceuticals UK Ltd. from 1999 to 2001.
General Manager at Novartis Pharmaceuticals Canada, Inc. from 2001 to 2003.
Chief Marketing Officer & Executive Vice President at Roche Group in 2009.
Vice President-Sales & Marketing at Sanofi and IVAX LLC.
Vice President-Sales at Aventis SA and IVAX Pharmaceuticals, Inc. Independent Director at GoodRx Holdings, Inc. from 2024 to 2026.
Member of Economic Advisory Council and Member-BioFulcrum Board at The J.
David Gladstone Institutes.
Education includes undergraduate degree from The University of Southampton.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
01/06/2026 14,490 ( 0.01% ) 781 156 $ 29/04/2026
17/03/2026 19,396 ( 0% ) 652 289 $ 29/04/2026
19/05/2026 2,975 ( 0% ) 259 063 $ 29/04/2026
07/07/2025 100,150 ( 0.09% ) 236 354 $ 29/04/2026
26/05/2026 21,727 ( 0.04% ) 191 198 $ 29/04/2026
22/04/2026 0 ( -.--% ) - $ 29/04/2026
30/03/2026 0 ( -.--% ) - $ 29/04/2026

Ian Clark active positions

CompaniesPositionStart
CORVUS PHARMACEUTICALS, INC. Director/Board Member 02/01/2017
GUARDANT HEALTH, INC. Director/Board Member 30/11/2016
OLEMA PHARMACEUTICALS, INC. Chairman 31/07/2020
KYVERNA THERAPEUTICS, INC. Director/Board Member 11/01/2026
TAKEDA PHARMACEUTICAL COMPANY LIMITED Director/Board Member 31/12/2018
BIOMARIN PHARMACEUTICAL INC. Chairman 01/06/2026
Chairman -
Director/Board Member 13/02/2022
Corporate Officer/Principal -

Former positions of Ian Clark

CompaniesPositionEnd
░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
See the detail of Ian Clark's experience

Training of Ian Clark

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

83

1st degree connections

38

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies38

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Non-Durables

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Distribution Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Solazyme, Inc.

Economic Advisory Council